Tscan Therapeutics Inc (TCRX:NASDAQ)

$1.1 -0.01 (-0.90%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 84

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed Tscan Therapeutics Inc (TCRX:NASDAQ) News Sources

TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102 ...

Yahoo Finance

external link

TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference

Yahoo Finance

external link
TCRX stock
TCRX stock price
TCRX stock price today
TCRX stock prediction
TCRX earnings date
TCRX news
TCRX price
TCRX share
TCRX share price
TCRX shares
TCRX ceo
TCRX premarket
$TCRX
TCRX ticker
TCRX after hours
TCRX stock
TCRX stock price
TCRX stock price today
TCRX stock prediction
TCRX earnings date
TCRX news
TCRX price
TCRX share
TCRX share price
TCRX shares
TCRX ceo
TCRX premarket
$TCRX
TCRX ticker
TCRX after hours

Tscan Therapeutics Inc (TCRX:NASDAQ) FAQs

toggle

What is the current price of Tscan Therapeutics Inc (TCRX:NASDAQ)?

The current price of Tscan Therapeutics Inc (TCRX:NASDAQ) is $1.1.


toggle

Tscan Therapeutics Inc (TCRX:NASDAQ) absolute price change since previous trading day?

The absolute price change of Tscan Therapeutics Inc (TCRX:NASDAQ) since the previous trading day is $-0.01.


toggle

Tscan Therapeutics Inc (TCRX:NASDAQ) percentage price change since previous trading day?

The percentage price change of Tscan Therapeutics Inc (TCRX:NASDAQ) since the previous trading day is -0.90%.


toggle

What is This Week's average sentiment score for Tscan Therapeutics Inc (TCRX:NASDAQ)?

This Week's average sentiment score for Tscan Therapeutics Inc (TCRX:NASDAQ) is 84 out of 100.


toggle

What is This Week's average sentiment for Tscan Therapeutics Inc (TCRX:NASDAQ)?

This Week's sentiment for Tscan Therapeutics Inc (TCRX:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.